Skip to main content

Analysts Offer Insights on Technology Companies: Lumexa Imaging Holdings, Inc. (LMRI) and Dell Technologies (DELL)

Tipranks - Tipranks - Tue Mar 3, 9:08AM CST

There’s a lot to be optimistic about in the Technology sector as 2 analysts just weighed in on Lumexa Imaging Holdings, Inc. (LMRI – Research Report) and Dell Technologies (DELL – Research Report) with bullish sentiments.

Claim 70% Off TipRanks Premium

Lumexa Imaging Holdings, Inc. (LMRI)

William Blair analyst Ryan Daniels maintained a Buy rating on Lumexa Imaging Holdings, Inc. today. The company’s shares closed last Monday at $14.30.

According to TipRanks.com, Daniels is a 1-star analyst with an average return of -0.2% and a 39.7% success rate. Daniels covers the Healthcare sector, focusing on stocks such as Hinge Health, Inc. Class A, Lifestance Health Group, and Pediatrix Medical Group. ;'>

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Lumexa Imaging Holdings, Inc. with a $22.71 average price target.

See the top stocks recommended by analysts >>

Dell Technologies (DELL)

Argus Research analyst Jim Kelleher reiterated a Buy rating on Dell Technologies on February 27 and set a price target of $200.00. The company’s shares closed last Monday at $146.99.

According to TipRanks.com, Kelleher is a top 100 analyst with an average return of 31.2% and a 69.1% success rate. Kelleher covers the Technology sector, focusing on stocks such as International Business Machines, Telefonaktiebolaget LM Ericsson, and Hewlett Packard Enterprise. ;'>

Dell Technologies has an analyst consensus of Strong Buy, with a price target consensus of $165.77, implying a 13.0% upside from current levels. In a report issued on February 13, TipRanks – Google also upgraded the stock to Buy with a $137.00 price target.

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).